Atherosclerosis-An immune disease The Anitschkov Lecture 2007HANSSON, Göran K.Atherosclerosis. 2009, Vol 202, Num 1, pp 2-10, issn 0021-9150, 9 p.Article

Immune mechanisms in AtherosclerosisHANSSON, Göran K.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 12, pp 1876-1890, issn 1079-5642Article

Leukotriene receptors in atherosclerosisBÄCK, Magnus; HANSSON, Göran K.Annals of medicine (Helsinki). 2006, Vol 38, Num 7, pp 493-502, issn 0785-3890, 10 p.Article

The Discovery of Cellular Immunity in the Atherosclerotic PlaqueHANSSON, Göran K; JONASSON, Lena.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 11, pp 1714-1717, issn 1079-5642, 4 p.Article

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapiesKLINGENBERG, Roland; HANSSON, Göran K.European heart journal. 2009, Vol 30, Num 23, pp 2838-2844, issn 0195-668X, 7 p.Article

Chemokines and atherosclerosisSHEIKINE, Yuri; HANSSON, Göran K.Annals of medicine (Helsinki). 2004, Vol 36, Num 2, pp 98-118, issn 0785-3890, 21 p.Article

T cells in atherogenesis : For better or for worse?ROBERTSON, Anna-Karin L; HANSSON, Göran K.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 11, pp 2421-2432, issn 1079-5642, 12 p.Article

Immunomodulation of atherosclerosis: Implications for vaccine developmentNILSSON, Jan; HANSSON, Göran K; SHAH, Prediman K et al.Arteriosclerosis, thrombosis, and vascular biology. 2005, Vol 25, Num 1, pp 18-28, issn 1079-5642, 11 p.Article

Cellular immunity, low-density lipoprotein and atherosclerosis: Break of tolerance in the artery wall : Immunology of atherosclerosisKETELHUTH, Daniel F. J; HANSSON, Göran K.Thrombosis and haemostasis. 2011, Vol 106, Num 5, pp 779-786, issn 0340-6245, 8 p.Article

Progress and challenges in translating the biology of atherosclerosis : CARDIOVASCULAR BIOLOGYLIBBY, Peter; RIDKER, Paul M; HANSSON, Göran K et al.Nature (London). 2011, Vol 473, Num 7347, pp 317-325, issn 0028-0836, 9 p.Article

Nuclear factor kappa-B and the heartVALEN, Guro; YAN, Zhong-Qun; HANSSON, Goran K et al.Journal of the American College of Cardiology. 2001, Vol 38, Num 2, pp 307-314, issn 0735-1097Article

Innate immunity, macrophage activation, and atherosclerosisYAN, Zhong-Qun; HANSSON, Göran K.Immunological reviews. 2007, Vol 219, pp 187-203, issn 0105-2896, 17 p.Article

Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activationEDFELDT, Kristina; SWEDENBORG, Jesper; HANSSON, Göran K et al.Circulation (New York, N.Y.). 2002, Vol 105, Num 10, pp 1158-1161, issn 0009-7322Article

5-lipoxygenase-activating protein : A potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammationBÄCK, Magnus; SULTAN, Ariane; OVCHINNIKOVA, Olga et al.Circulation research. 2007, Vol 100, Num 7, pp 946-949, issn 0009-7330, 4 p.Article

Transfer of CD4⁺ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout miceXINGHUA ZHOU; NICOLETTI, Antonino; ELHAGE, Rima et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 24, pp 2919-2922, issn 0009-7322Article

Vaccination against atherosclerosis? Induction of atheroprotective immunityHANSSON, Göran K; NILSSON, Jan.Seminars in immunopathology (Print). 2009, Vol 31, Num 1, pp 95-101, issn 1863-2297, 7 p.Article

Thrombin inhibitor reduces myocardial infarction in apoE^-/- × LDLR^-/- miceHEMDAHL, Anne-Louise; FALK, Erling; THOREN, Peter et al.American journal of physiology. Heart and circulatory physiology. 2004, Vol 56, Num 2, pp 872-877, issn 0363-6135, 6 p.Article

Inflammation in Atherosclerosis: From Pathophysiology to PracticeLIBBY, Peter; RIDKER, Paul M; HANSSON, Göran K et al.Journal of the American College of Cardiology. 2009, Vol 54, Num 23, pp 2129-2138, issn 0735-1097, 10 p.Article

Innate and adaptive immunity in the pathogenesis of atherosclerosisHANSSON, Göran K; LIBBY, Peter; SCHÖNBECK, Uwe et al.Circulation research. 2002, Vol 91, Num 4, pp 281-291, issn 0009-7330Article

T Cell-based Therapies for Atherosclerosis : Novel Targets and Biomarkers for Anti-atherosclerotic TherapyKETELHUTH, Daniel F. J; GISTERA, Anton; JOHANSSON, Daniel K et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5850-5858, issn 1381-6128, 9 p.Article

Innate immune signals in atherosclerosisLUNDBERG, Anna M; HANSSON, Göran K.Clinical immunology (Orlando, Fla. Print). 2010, Vol 134, Num 1, pp 5-24, issn 1521-6616, 20 p.Article

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosisXINGHUA ZHOU; CALIGIURI, Giuseppina; HAMSTEN, Anders et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 1, pp 108-114, issn 1079-5642Article

Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injurySIRSJÖ, Allan; LÖFVING, Anders; HANSSON, Göran K et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 897-902, issn 0160-2446, 6 p.Article

Expression of interleukin-15 in mouse and human atherosclerotic lesionsWUTTGE, Dirk Marcus; ERIKSSON, Per; SIRSJÖ, Allan et al.The American journal of pathology. 2001, Vol 159, Num 2, pp 417-423, issn 0002-9440Article

Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe^―/― miceHJERPE, Charlotta; JOHANSSON, Daniel; HERMANSSON, Andreas et al.Atherosclerosis. 2010, Vol 209, Num 2, pp 436-441, issn 0021-9150, 6 p.Article